Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.04.16
关于公司首次果真刊行股票之刊行保荐事情报告
2010.04.16
非经常性损益情形的鉴证报告
2010.04.16
北京市中伦金通状师事务所关于为公司首次果真刊行股票并上市出具执法意见书的状师事情...
2010.04.16
股东大会有关本次刊行的决议
2010.04.16
董事会有关本次刊行的决议
2010.04.16
北京市中伦金通状师事务所关于公司首次果真刊行股票并上市的执法意见书
2010.04.16
北京市中伦状师事务所关于公司首次果真刊行股票并上市的增补执法意见书(一)
2010.04.16
首次果真刊行股票招股意向书
2010.04.16
首次果真刊行股票招股意向书摘要
2010.04.16
中国证监会关于批准公司首次果真刊行股票的批复
第一页
上一页
148
149
150
151
152
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】